Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population

References

• Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:362–366.
   PubMed Web of Science ®Google Scholar
• Moum B, Vatn MH, Ekbom A, et al. Incidence of Crohn’s disease in four counties in southeastern Norway, 1990–93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:355–361.
   PubMed Web of Science ®Google Scholar
• Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237–247.
   PubMedGoogle Scholar
• Loftus EV Jr, Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.
   PubMed Web of Science ®Google Scholar
• Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.
   PubMed Web of Science ®Google Scholar
• Jelsness-Jorgensen LP, Bernklev T, Henriksen M, et al. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis. 2011;17:1564–1572.
   PubMed Web of Science ®Google Scholar
• O’Sullivan M. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? Proc Nutr Soc. 2015;74:5–12.
   PubMed Web of Science ®Google Scholar
• Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011;35:308–316.
   PubMed Web of Science ®Google Scholar
• Siffledeen JS, Siminoski K, Steinhart H, et al. The frequency of vitamin D deficiency in adults with Crohn’s disease. Can J Gastroenterol. 2003;17:473–478.
   PubMed Web of Science ®Google Scholar
• Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med. 1996;239:131–137.
   PubMed Web of Science ®Google Scholar
• Sadeghian M, Saneei P, Siassi F, et al. Vitamin D status in relation to Crohn’s disease: meta-analysis of observational studies. Nutrition. 2016;32:505–514.
   PubMed Web of Science ®Google Scholar
• Suibhne TN, Cox G, Healy M, et al. Vitamin D deficiency in Crohn’s disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis. 2012;6:182–188.
   PubMed Web of Science ®Google Scholar
• Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39:125–136.
   PubMed Web of Science ®Google Scholar
• Garg M, Lubel JS, Sparrow MP, et al. Review article: vitamin D and inflammatory bowel disease – established concepts and future directions. Aliment Pharmacol Ther. 2012;36:324–344.
   PubMed Web of Science ®Google Scholar
• Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39:690–697.
   PubMed Web of Science ®Google Scholar
• Moum B, Aadland E, Ekbom A, et al. Seasonal variations in the onset of ulcerative colitis. Gut. 1996;38:376–378.
   PubMed Web of Science ®Google Scholar
• Zeng L, Anderson FH. Seasonal change in the exacerbations of Crohn’s disease. Scand J Gastroenterol. 1996;31:79–82.
   PubMed Web of Science ®Google Scholar
• Nerich V, Jantchou P, Boutron-Ruault MC, et al. Low exposure to sunlight is a risk factor for Crohn’s disease. Aliment Pharmacol Ther. 2011;33:940–945.
   PubMed Web of Science ®Google Scholar
• Theodoratou E, Tzoulaki I, Zgaga L, et al. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.
   PubMed Web of Science ®Google Scholar
• Jahnsen J, Falch JA, Mowinckel P, et al. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192–199.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–1930.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281.
   PubMed Web of Science ®Google Scholar
• Narula N, Marshall JK. Management of inflammatory bowel disease with vitamin D: beyond bone health. J Crohns Colitis. 2012;6:397–404.
   PubMed Web of Science ®Google Scholar
• Ardesia M, Ferlazzo G, Fries W. Vitamin d and inflammatory bowel disease. Biomed Res Int. 2015;2015:470805.
   PubMed Web of Science ®Google Scholar
• Jorgensen SP, Hvas CL, Agnholt J, et al. Active Crohn’s disease is associated with low vitamin D levels. J Crohns Colitis. 2013;7:e407–e413.
   PubMedGoogle Scholar
• Raftery T, Merrick M, Healy M, et al. Vitamin D status is associated with intestinal inflammation as measured by fecal calprotectin in Crohn’s disease in clinical remission. Dig Dis Sci. 2015;60:2427–2435.
   PubMed Web of Science ®Google Scholar
• Garg M, Rosella O, Lubel JS, et al. Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2634–2643.
   PubMed Web of Science ®Google Scholar
• Kelly P, Suibhne TN, O’Morain C, et al. Vitamin D status and cytokine levels in patients with Crohn’s disease. Int J Vitam Nutr Res. 2011;81:205–210.
   PubMed Web of Science ®Google Scholar
• Blanck S, Aberra F. Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci. 2013;58:1698–1702.
   PubMed Web of Science ®Google Scholar
• Kabbani TA, Koutroubakis IE, Schoen RE, et al. Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study. Am J Gastroenterol. 2016;111:712–719.
   PubMed Web of Science ®Google Scholar
• Hart AL. Vitamin D and inflammatory bowel disease: chicken or egg? Inflamm Bowel Dis. 2013;19:459–460.
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA. “Vitamin D – why does it matter?” – defining vitamin D deficiency and its prevalence. Scand J Clin Lab Invest Suppl. 2012;243:3–6.
   PubMedGoogle Scholar
• Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28.
   PubMed Web of Science ®Google Scholar
• Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res. 2011;26:455–457.
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2–6. discussion 16–19.
   PubMedGoogle Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980;1:514.
   PubMed Web of Science ®Google Scholar
• Best WR. Predicting the Crohn’s disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis. 2006;12:304–310.
   PubMed Web of Science ®Google Scholar
• Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29–32.
   PubMed Web of Science ®Google Scholar
• Travis SP, Higgins PD, Orchard T, et al. Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther. 2011;34:113–124.
   PubMed Web of Science ®Google Scholar
• Walsh AJ, Ghosh A, Brain AO, et al. Comparing disease activity indices in ulcerative colitis. J Crohns Colitis. 2014;8:318–325.
   PubMed Web of Science ®Google Scholar
• D’Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132:763–786.
   PubMed Web of Science ®Google Scholar
• Vermeire S, Schreiber S, Sandborn WJ, et al. Correlation between the Crohn’s disease activity and Harvey-Bradshaw indices in assessing Crohn’s disease severity. Clin Gastroenterol Hepatol. 2010;8:357–363.
   PubMed Web of Science ®Google Scholar
• Kristensen V, Klepp P, Cvancarova M, et al. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin. J Crohns Colitis. 2015;9:164–169.
   PubMed Web of Science ®Google Scholar
• Ross AC. Institute of Medicine of the National Academies of 2011 dietary reference intakes for calcium and vitamin D. Washington (DC): The National Academies Press; 2011.
   Google Scholar
• Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–58.
   PubMed Web of Science ®Google Scholar
• WHO. Global recommendation on physical activity for health; 2010. Available from: http://www.who.int/dietphysicalactivity/publications/9789241599979/en.
   Google Scholar
• Meyer HE, Falch JA, Sogaard AJ, et al. Vitamin D deficiency and secondary hyperparathyroidism and the association with bone mineral density in persons with Pakistani and Norwegian background living in Oslo, Norway, The Oslo Health Study. Bone. 2004;35:412–417.
   PubMed Web of Science ®Google Scholar
• Larose TL, Chen Y, Camargo CA, Jr, et al. Factors associated with vitamin D deficiency in a Norwegian population: the HUNT Study. J Epidemiol Community Health. 2014;68:165–170.
   PubMed Web of Science ®Google Scholar
• Greene-Finestone LS, Berger C, de Groh M, et al. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioural correlates. Osteoporos Int. 2011;22:1389–1399.
   PubMed Web of Science ®Google Scholar
• Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008;57:1518–1523.
   PubMed Web of Science ®Google Scholar
• Dumitrescu G, Mihai C, Dranga M, et al. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World J Gastroenterol. 2014;20:2392–2396.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm Bowel Dis. 2013;19:1921–1927.
   PubMed Web of Science ®Google Scholar
• Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32:377–383.
   PubMed Web of Science ®Google Scholar
• Hlavaty T, Krajcovicova A, Koller T, et al. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World J Gastroenterol. 2014;20:15787–15796.
   PubMed Web of Science ®Google Scholar
• Yang Z, Laillou A, Smith G, et al. A review of vitamin D fortification: implications for nutrition programming in Southeast Asia. Food Nutr Bull. 2013;34:S81–S89.
   Web of Science ®Google Scholar
• Lewis JD, Aberra FN, Lichtenstein GR, et al. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology. 2004;126:665–673.
   PubMed Web of Science ®Google Scholar
• Cashman KD, Dowling KG, Skrabakova Z, et al. Standardising serum 25-hydroxyvitamin D data from four Nordic population samples using the Vitamin D Standardisation Programme protocols: shedding new light on vitamin D status in Nordic individuals. Scand J Clin Lab Invest. 2015;75:549–561.
   PubMed Web of Science ®Google Scholar